| Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ... Annals of the American Thoracic Society 16 (1), 22-28, 2019 | 690 | 2019 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 684* | 2021 |
| Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease REK Russell, SV Culpitt, C DeMatos, L Donnelly, M Smith, J Wiggins, ... American journal of respiratory cell and molecular biology 26 (5), 602-609, 2002 | 635 | 2002 |
| Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD SL Traves, SV Culpitt, REK Russell, PJ Barnes, LE Donnelly Thorax 57 (7), 590-595, 2002 | 513 | 2002 |
| Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms LE Donnelly, R Newton, GE Kennedy, PS Fenwick, RHF Leung, K Ito, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 287 (4 …, 2004 | 509 | 2004 |
| Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease SV Culpitt, DF Rogers, P Shah, C De Matos, REK Russell, LE Donnelly, ... American journal of respiratory and critical care medicine 167 (1), 24-31, 2003 | 487 | 2003 |
| Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial S Ramakrishnan, DV Nicolau, B Langford, M Mahdi, H Jeffers, ... The Lancet Respiratory Medicine 9 (7), 763-772, 2021 | 469 | 2021 |
| Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases REK Russell, A Thorley, SV Culpitt, S Dodd, LE Donnelly, C Demattos, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 283 (4 …, 2002 | 414 | 2002 |
| Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, ... The Lancet 398 (10303), 843-855, 2021 | 325 | 2021 |
| Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD SV Culpitt, DF Rogers, PS Fenwick, P Shah, C De Matos, REK Russell, ... Thorax 58 (11), 942-946, 2003 | 283 | 2003 |
| Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease SV Culpitt, C de Matos, RE Russell, LE Donnelly, DF Rogers, PJ Barnes American journal of respiratory and critical care medicine 165 (10), 1371-1376, 2002 | 264 | 2002 |
| Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids W Mattos, S Lim, R Russell, A Jatakanon, KF Chung, PJ Barnes Chest 122 (5), 1543-1552, 2002 | 240 | 2002 |
| Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD PA Ford, AL Durham, REK Russell, F Gordon, IM Adcock, PJ Barnes Chest 137 (6), 1338-1344, 2010 | 237 | 2010 |
| Eosinophils in COPD: just another biomarker? M Bafadhel, ID Pavord, REK Russell The Lancet Respiratory Medicine 5 (9), 747-759, 2017 | 225 | 2017 |
| ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions A Bourdin, L Bjermer, C Brightling, GG Brusselle, P Chanez, KF Chung, ... European respiratory journal 54 (3), 2019 | 128 | 2019 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 92 | 2023 |
| Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD C Costa, SL Traves, SJ Tudhope, PS Fenwick, KBR Belchamber, ... European Respiratory Journal 47 (4), 1093-1102, 2016 | 87 | 2016 |
| Expression of muscarinic receptors by human macrophages A Koarai, SL Traves, PS Fenwick, SM Brown, KK Chana, REK Russell, ... European Respiratory Journal 39 (3), 698-704, 2012 | 77 | 2012 |
| Expression of transient receptor potential C6 channels in human lung macrophages TK Finney-Hayward, MO Popa, P Bahra, S Li, CT Poll, M Gosling, ... American journal of respiratory cell and molecular biology 43 (3), 296-304, 2010 | 77 | 2010 |
| Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care H Pinnock, M Fletcher, S Holmes, D Keeley, J Leyshon, D Price, ... Primary Care Respiratory Journal 19 (1), 75-83, 2010 | 65 | 2010 |
Peter J BarnesImperial College LondonVerified email at imperial.ac.uk